Author

Timon P.H. Buys

Observed names: Buys, Timon PH, Buys, Timon Paul Hermus, T P H Buys, T. Buys, Timon Buys, Timon P H Buys, Timon P. Buys, Timon P. H. Buys, Timon PH Buys, Timon Ph Buys

Observed institutions: BC Cancer Agency, University of British Columbia, Drexel University

OpenAlex ID: A5108439356

Genetic alteration and gene expression modulation during cancer progression.

2004 · Cathie Garnis, Timon PH Buys, et al. · Molecular Cancer · 149

PDF

Epidermal growth factor receptor (EGFR) is transcriptionally induced by the Y-box binding protein-1 (YB-1) and can be inhibited with Iressa in basal-like breast cancer, providing a potential target for therapy

2007 · Anna L Stratford, Golareh Habibi, et al. · Breast Cancer Research · 144

PDF

Integrative Genomic Analyses Identify BRF2 as a Novel Lineage-Specific Oncogene in Lung Squamous Cell Carcinoma

2010 · William W. Lockwood, Raj Chari, et al. · PLoS Medicine · 100

PDF

Genomic Landscape of Malignant Mesotheliomas

2016 · Shumei Kato, Brett N. Tomson, et al. · Molecular Cancer Therapeutics · 88

Chromosome 5p aberrations are early events in lung cancer: implication of glial cell line-derived neurotrophic factor in disease progression

2005 · Cathie Garnis, Jonathan J Davies, et al. · Oncogene · 63

Genomic imbalances in precancerous tissues signal oral cancer risk

2009 · Cathie Garnis, Raj Chari, et al. · Molecular Cancer · 54

PDF

EYA4 is inactivated biallelically at a high frequency in sporadic lung cancer and is associated with familial lung cancer risk

2013 · I M Wilson, E A Vucic, et al. · Oncogene · 49

2010 · V D Martinez, T P H Buys, et al. · British Journal of Cancer · 48

PDF

Cell-Cycle Gene Alterations in 4,864 Tumors Analyzed by Next-Generation Sequencing: Implications for Targeted Therapeutics

2016 · Teresa Helsten, Shumei Kato, et al. · Molecular Cancer Therapeutics · 42

Genetic changes in the evolution of multidrug resistance for cultured human ovarian cancer cells

2007 · Timon P. H. Buys, Raj Chari, et al. · Genes Chromosomes and Cancer · 41

Integrative genomic and gene expression analysis of chromosome 7 identified novel oncogene loci in non-small cell lung cancer

2008 · Jennifer M. Campbell, William W. Lockwood, et al. · Genome · 29

Evaluation of HPV Infection and Smoking Status Impacts on Cell Proliferation in Epithelial Layers of Cervical Neoplasia

2014 · Martial Guillaud, Timon P. H. Buys, et al. · PLoS ONE · 22

PDF

Accuracy of optical spectroscopy for the detection of cervical intraepithelial neoplasia without colposcopic tissue information; a step toward automation for low resource settings

2012 · Jose-Miguel Yamal, Getie A. Zewdie, et al. · Journal of Biomedical Optics · 16

PDF

Defining Genomic Alteration Boundaries for a Combined Small Cell and Non-small Cell Lung Carcinoma

2009 · Timon P.H. Buys, Sarit Aviel-Ronen, et al. · Journal of Thoracic Oncology · 16

Public Databases and Software for the Pathway Analysis of Cancer Genomes

2007 · Ivy F.L. Tsui, Raj Chari, et al. · Cancer Informatics · 15

Optical Technologies and Molecular Imaging for Cervical Neoplasia: A Program Project Update

2011 · Timon P.H. Buys, Scott B. Cantor, et al. · Gender Medicine · 13

Genomic landscape of malignant mesotheliomas.

2016 · Shumei Kato, Brett N. Tomson, et al. · Journal of Clinical Oncology · 11

Public databases and software for the pathway analysis of cancer genomes.

2007 · Ivy F L Tsui, Raj Chari, et al. · PubMed · 11

A framework for quantitative assessment of Ki67 distribution in preneoplastic bronchial epithelial lesions.

2012 · Mehrnoush Khojasteh, Timon P H Buys, et al. · PubMed · 4

Malignancy-Associated Changes

2015 · Timon P. H. Buys, Wan L. Lam · Springer eBooks · 1

E13. Identification of genomic changes associated with resistanceto standard chemotherapy in a xenograft model of human NSCLC

2005 · Timon P.H. Buys, Yuzhuo Wang, et al. · Lung Cancer · 1

Supplemental tables and figure from Genomic Landscape of Malignant Mesotheliomas

2023 · Shumei Kato, Brett N. Tomson, et al.

Supplemental Tables from Cell-Cycle Gene Alterations in 4,864 Tumors Analyzed by Next-Generation Sequencing: Implications for Targeted Therapeutics

2023 · Teresa Helsten, Shumei Kato, et al.

Supplemental Figures from Cell-Cycle Gene Alterations in 4,864 Tumors Analyzed by Next-Generation Sequencing: Implications for Targeted Therapeutics

2023 · Teresa Helsten, Shumei Kato, et al.

Supplemental Table 2 from Cell-Cycle Gene Alterations in 4,864 Tumors Analyzed by Next-Generation Sequencing: Implications for Targeted Therapeutics

2023 · Teresa Helsten, Shumei Kato, et al.

Works count: 57

Citation count: 917

H-index: 15

I10-index: 18